IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy

Clinical trial NCT01727531 · COMPLETED

Trial details

NCT number: NCT01727531
Sponsor: Main Line Health
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Brain Metastasis

Start date: 2008-12-01
Primary completion: 2013-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.